DK1636239T3 - Indolderivater med en forbedret antipsykotisk aktivitet - Google Patents

Indolderivater med en forbedret antipsykotisk aktivitet

Info

Publication number
DK1636239T3
DK1636239T3 DK04741649T DK04741649T DK1636239T3 DK 1636239 T3 DK1636239 T3 DK 1636239T3 DK 04741649 T DK04741649 T DK 04741649T DK 04741649 T DK04741649 T DK 04741649T DK 1636239 T3 DK1636239 T3 DK 1636239T3
Authority
DK
Denmark
Prior art keywords
sup
sub
receptors
indole derivatives
relates
Prior art date
Application number
DK04741649T
Other languages
English (en)
Inventor
Jose M Bartolome-Nebreda
Jose Ignacio Andres-Gil
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK1636239T3 publication Critical patent/DK1636239T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Light Guides In General And Applications Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK04741649T 2003-05-30 2004-05-26 Indolderivater med en forbedret antipsykotisk aktivitet DK1636239T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2003/005789 WO2004106298A1 (en) 2003-05-30 2003-05-30 Indole derivatives with an improved antipsychotic activity
PCT/EP2004/050922 WO2004106346A1 (en) 2003-05-30 2004-05-26 Indole derivatives with an improved antipsychotic activity

Publications (1)

Publication Number Publication Date
DK1636239T3 true DK1636239T3 (da) 2007-10-29

Family

ID=33483768

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04741649T DK1636239T3 (da) 2003-05-30 2004-05-26 Indolderivater med en forbedret antipsykotisk aktivitet

Country Status (10)

Country Link
US (1) US20070066608A1 (da)
JP (1) JP2006528957A (da)
AT (1) ATE367392T1 (da)
AU (1) AU2004242802A1 (da)
CA (1) CA2525282A1 (da)
DE (1) DE602004007658T2 (da)
DK (1) DK1636239T3 (da)
ES (1) ES2289533T3 (da)
PT (1) PT1636239E (da)
WO (2) WO2004106298A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311837B1 (en) 2004-03-30 2014-05-21 Vertex Pharmaceuticals Inc. Azaindoles useful as inhibitors of jak and other protein kinases
JP4896476B2 (ja) * 2005-09-16 2012-03-14 広栄化学工業株式会社 メチルオキシメチルアミノピリジン誘導体及びその製造方法
MX2009006700A (es) 2006-12-21 2009-06-30 Vertex Pharma Derivados de 5-ciano-4-(pirolo)[2,3b]piridina-3-il)-pirimidinas utiles como inhibidores de proteina-cinasas.
GB0708186D0 (en) * 2007-04-27 2007-06-06 Merck Sharp & Dohme Therapeutic compounds
AU2009335709A1 (en) 2008-12-19 2011-07-14 Supernus Pharmaceuticals, Inc. Method of treatment of aggression
SG176722A1 (en) 2009-06-17 2012-01-30 Vertex Pharma Inhibitors of influenza viruses replication
WO2011044134A1 (en) * 2009-10-05 2011-04-14 Albany Molecular Research, Inc. Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof
JP6063377B2 (ja) 2010-03-31 2017-01-18 スパーナス ファーマシューティカルズ インコーポレイテッド Ｃｎｓ化合物の安定化製剤
AU2011343642A1 (en) 2010-12-16 2013-05-02 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
US9067949B2 (en) 2011-01-19 2015-06-30 Albany Molecular Research, Inc. Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP3421468B1 (en) 2013-11-13 2020-11-04 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication
EP3578554A1 (en) 2013-11-13 2019-12-11 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
WO2016183116A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication
JP6857617B2 (ja) 2015-05-13 2021-04-14 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ インフルエンザウイルスの複製の阻害剤
US11072602B2 (en) 2016-12-06 2021-07-27 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
MX2022009528A (es) 2020-02-04 2022-11-14 Mindset Pharma Inc Derivados de 3-pirrolidina-indol como agentes psicodélicos serotoninérgicos para el tratamiento de trastornos del snc.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2421900A1 (fr) * 1977-03-17 1979-11-02 Sauba Lab Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
TW446706B (en) * 1995-02-07 2001-07-21 Janssen Pharmaceutica Nv Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines, a pharmaceutical composition containing them, their intermediates and a process for their preparation
TW546299B (en) * 1999-01-07 2003-08-11 Wyeth Corp 3,4-dihydro-2H-benzo[1,4]oxazinyl-methyl-[3-(1H-indol-3-yl)-alkyl]-amines
WO2000040581A1 (en) * 1999-01-07 2000-07-13 American Home Products Corporation 3,4-dihydro-2h-benzo[1,4]oxazine derivatives
US6313126B1 (en) * 1999-01-07 2001-11-06 American Home Products Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
US6559169B2 (en) * 2001-04-24 2003-05-06 Wyeth Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-benzodioxan
US6656950B2 (en) * 2001-04-25 2003-12-02 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine

Also Published As

Publication number Publication date
ATE367392T1 (de) 2007-08-15
JP2006528957A (ja) 2006-12-28
AU2004242802A1 (en) 2004-12-09
DE602004007658D1 (de) 2007-08-30
WO2004106298A1 (en) 2004-12-09
CA2525282A1 (en) 2004-12-09
PT1636239E (pt) 2007-09-24
WO2004106346A1 (en) 2004-12-09
ES2289533T3 (es) 2008-02-01
US20070066608A1 (en) 2007-03-22
DE602004007658T2 (de) 2008-04-10

Similar Documents

Publication Publication Date Title
DK1636239T3 (da) Indolderivater med en forbedret antipsykotisk aktivitet
MX2007012883A (es) Derivados de dihidrobenzofurano y usos de los mismos.
EA200701583A1 (ru) Гетероциклические тетрациклические производные гидрофурана в качестве ингибиторов 5нт2 в терапии расстройств цнс
MX2007012936A (es) Derivados de dihidrobenzofurano y usos de los mismos.
MX2007013021A (es) Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c.
IL177291A0 (en) Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
SK286066B6 (sk) Derivát N-(indolkarbonyl)piperazínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje
ATE449082T1 (de) (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl) amine mit aktivität am 5-ht-rezeptor
SK287018B6 (sk) Deriváty fenylpiperazínov, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitie
EA200300519A1 (ru) Соединения производных бензотиофена, способ их получения и применения
ATE443707T1 (de) Isoxazolin-indol-derivate mit verbesserter antipsychotischer und anxiolytischer aktivität
MY125295A (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives
ATE318266T1 (de) 3-substituierte chinolin-4- carbonsäureamidderivate als nk-3- und nk-2- rezeptorantagonisten
SK9232001A3 (en) Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
TW200612899A (en) Novel tetracyclic tetrahydrofuran derivatives
DE60111464D1 (de) Azabicycloalkan-Derivate zur Verwendung als Inhibitoren der Serotonin-Wiederaufnahme und als 5HT2a Antagonisten
RS20050892A (en) Imidazole derivatives as glutamate receptor antagonists
WO2006061392A3 (en) Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
EA200702626A1 (ru) Новые замещённые тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена и их применение в качестве лекарственного средства
RU2007125691A (ru) Бенздиоксановые производные пиперазина с комбинацией сродства к допаминовым-d2 рецепторам и участкам обратного захвата серотонина
KR100859107B1 (ko) 도파민 ｄ2 수용체 및 세로토닌 재흡수 부위에 대한친화도가 높은8-｛4-[3-(5-플루오로-1ｈ-인돌-3-일)-프로필]-피페라진-1-일｝-2-메틸-4ｈ-벤조[1,4]옥사진-3-온 메실레이트
MY123686A (en) Indole derivatives and their use as 5ht2a ligands
MXPA05010483A (es) Cromenonindoles.
DE602004016177D1 (de) Methylindole und methylpyrrolopyridine als alpha-1-adrenerge agonisten
WO2006000555A3 (en) Novel unsaturated tetracyclic tetrahydrofuran derivatives